共 50 条
- [25] Dual add-on therapy of gemigliptin and dapagliflozin in patients with type 2 diabetes inadequately controlled with metformin alone: The SOLUTION 2 study [J]. DIABETES OBESITY & METABOLISM, 2024, 26 (09): : 3743 - 3752
- [28] A 52-week extension study of switching from gemigliptin vs sitagliptin to gemigliptin only as add-on therapy for patients with type 2 diabetes who are inadequately controlled with metformin alone [J]. DIABETES OBESITY & METABOLISM, 2018, 20 (06): : 1535 - 1541